Inhibition of spinal nitric oxide synthase by N(ω)-nitro-L-arginine blocks the release of Met-enkephalin and antinociception induced by supraspinally administered β-endorphin in the rat

Neuroscience

Volumn 78, Issue 2, 1997, Pages 461-467

  Tseng, L F ^a   Wang, H Q ^a   Xu, J Y ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

endorphin; antinociception; Met enkephalin release; N( ) nitro L arginine; nitric oxide; tail flick inhibition

Indexed keywords

BETA ENDORPHIN; DELTORPHIN; METENKEPHALIN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; TAIL FLICK TEST;

ANALGESICS; ANIMALS; BETA-ENDORPHIN; ENKEPHALIN, METHIONINE; ENZYME INHIBITORS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; NITRIC OXIDE SYNTHASE; NITROARGININE; OLIGOPEPTIDES; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0031562367     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00581-7     Document Type: Article

References (25)

1. 1. D'Amour F. E. and Smith D. L. (1941) A method for determining loss of pain sensation. J. Pharmac. exp. Ther. 72, 74-79.
2. 2. Feldberg W. and Smyth D. G. (1977) The C fragment of lipotropin - an endogenous potent analgesic peptide. Br. J. Pharmac. 60, 445-453.
3. 3. Fu T. C. and Dewey W. L. (1981) A new technique for the in vivo bioassay of opiates and other drugs on mouse spinal cord. Eur. J. Pharmac. 74, 239-242.
4. 4. Guillemin R., Ling N. and Vargo T. (1977) Radioimmunoassays for α-endorphin and β-endorphin. Biochem. biophys. Res. Commun. 77, 361-366.
5. 5. Hara S., Kuhns E. R., Ellenberger E. A., Mueller J. L., Shibuya T., Endo T. and Quock R. M. (1995) Involvement of nitric oxide in intracerebroventricular beta-endorphin-induced neuronal release of Methionine-enkephalin. Brain Res. 675, 190-194.
6. 6. Loh H. H., Tseng L. F., Wei E. and Li C. H. (1976) β-Endorphin is a potent analgesic agent. Proc. natn. Acad. Sci. U.S.A. 73, 2895-2898.
7. 7. Suh H. H. and Tseng L. F. (1990) Delta-but not mu-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice. J. Pharmac. exp. Ther. 253, 981-986.
8. 8. Suh H. H. and Tseng L. F. (1990) Intrathecal administration of thiorphan and bestatin enhances the antinociception and release of Met-enkephalin induced by β-endorphin given intraventricularly in anesthetized rats. Neuropeptides 16, 91-96.
9. 9. Tseng L. F. (ed.) (1995) Mechanism of β-endorphin-induced antinociception. In The Pharmacology of Opioid Peptides, pp. 249-269. Harwood Academic, Switzerland.
10. 10. Tseng L. F. and Collins K. A. (1991) Different mechanisms mediating tail-flick inhibition induced by β-endorphin, DAMGO and morphine from ROb and GiA in anesthetized rats. J. Pharmac. exp. Ther. 257, 530-538.
11. 11. Tseng L. F. and Collins K. A. (1993) Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse. J. Pharmac. exp. Ther. 266, 1430-1438.
12. 12. Tseng L. F. and Fujimoto J. M. (1984) Evidence that spinal endorphin mediates intraventricular β-endorphin-induced tail-flick inhibition and catalepsy. Brain Res. 302, 231-237.
13. 13. Tseng L. F. and Fujimoto J. M. (1985) Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular β-endorphin and morphine in rats. J. Pharmac. exp. Ther. 232, 74-79.
14. 14. Tseng L. F., Higgins M. J., Hong J.-S., Hudson P. M. and Fujimoto J. M. (1985) Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats. Brain Res. 343, 60-69.
15. 15. Tseng L. F., King R. C. and Fujimoto J. M. (1986) Release of immunoreactive Met-enkephalin by intraventricular beta-endorphin in the anesthetized rats. Regul. Pept. 14, 181-192.
16. 16. Tseng L. F., Ostwald T. J., Loh H. H. and Li C. H. (1979) Behavioral activities of opioid peptides and morphine sulfate in golden hamsters and rats. Psychopharmacology 64, 215-218.
17. 5]enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice. Eur. J. Pharmac. 173, 171-176.
18. 18. Tseng L. F., Wei E. T., Loh H. H. and Li C. H. (1980) β-Endorphin: central sites of analgesia, catalepsy and body temperature changes in rats. J. Pharmac. exp. Ther. 214, 328-332.
19. 19. Tseng L. F. and Xu J. Y. (1994) The modulatory role of NO/cyclic GMP on i.c.v. morphine- and β-endorphin-induced antinociception in the mouse. XIIth International Congress of Pharmacology, Montreal, Canada.
20. 20. Tseng L. F., Xu J. J. and Pieper G. M. (1992) Increase of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphin-induced antinociception in the mouse. Eur. J. Pharmac. 212, 301-303.
21. 21. Xu J. Y., Pieper G. M. and Tseng L. F. (1995) Activation of an NO-cyclic GMP system by NO donors potentiates β-endorphin-induced antinociception in the mouse. Pain 63, 377-383.
22. 22. Xu J. Y. and Tseng L. F. (1993) Increase of nitric oxide by L-arginine potentiates β-endorphin-but not μ-, δ-or κ-opioid agonist-induced antinociception in the mouse. Eur. J. Pharmac. 236, 137-142.
23. 23. Xu J. Y. and Tseng L. F. (1994) Role of nitric oxide/cyclic GMP in i.c.v. administered β-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse. Eur. J. Pharmac. 262, 223-231.
24. 24. Xu J. Y. and Tseng L. F. (1995) Nitric oxide/cyclic guanoside monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and β-endorphin-induced antinociception in the mouse. J. Pharmac. exp. Ther. 274, 8-16.
25. 25. Zimmermann M. (1983) Ethical guidelines for the investigations of experimental pain in the conscious animals. Pain 16, 109-110.